Optical coherence tomography: a key to the future management of patients with diabetic macular oedema.

  • Massin P
  • Girach A
  • Erginay A
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Diabetic macular oedema is a major cause of visual loss in patients
with diabetes. It usually results from the breakdown of the inner
blood-retinal barrier. Early detection of retinal abnormalities is
vital in preventing diabetic macular oedema and subsequent loss of
vision, whilst assessment of retinal thickness is important for treatment
and follow-up. Until recently, however, the methods available for
detecting and evaluating diabetic macular oedema were slit-lamp biomicroscopy
and stereoscopic photography, both of which are limited in detecting
earlier retinal changes. Optical coherence tomography (OCT) is a
new diagnostic imaging modality that provides high-resolution, cross-sectional
images of the eye. It is proving to be an accurate tool for the early
diagnosis, analysis and monitoring of retinopathy, with high repeatability
and resolution. It allows not only the qualitative diagnosis of diabetic
macular oedema, but also the quantitative assessment of oedema. This
article reviews the future role of OCT in the management of patients
with diabetic macular oedema.

Author-supplied keywords

  • Blood-Retinal Barrier; Diabetic Retinopathy; Human
  • Cystoid; Reproducibility of Results; Retina; Tomo
  • Optical Coherence

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PMID: 16879566


  • Pascale Massin

  • Aniz Girach

  • Ali Erginay

  • Alain Gaudric

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free